A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.
Investigational Drug Gaining Traction Via Social Media
Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Followers are encouraged to message these profiles directly for source information, while also receiving discount codes.
Thriving Commerce on Messaging Platforms
Additionally, a robust trade exists on messaging services, where communities with numerous of members share “before and after” photos, administration instructions and claims of rapid UK delivery. Vendors market the substance there before directing customers to WhatsApp for purchases.
Understanding Retatrutide
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Healthcare Professionals Voice Worries
Nevertheless, physicians and chemists have warned that the sale of what is still an unapproved drug in the United Kingdom is worrisome and could result in individuals administering substances of uncertain source.
Several experts said the demand for the experimental drug could be connected to the increasing cost of approved weight loss products such as Mounjaro.
Legal Status and Implementation
Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that cannot be promoted or distributed for personal consumption under the British medical regulations.
Some influencers try to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, prosecution or imprisonment.
Platform Reaction and Material Removal
Based on TikTok, the platform has taken down violative content and banned associated keywords and query recommendations. The company said it was dedicated to maintaining the service safe and allocating resources in enhancing enforcement strategies.
Digital Trading Activities
Investigations also found communities with up to 9,000 participants selling the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly brings up channels with thousands of members, filled with photos of slimming results, glowing reviews and step-by-step guides for mixing or injecting at home.
After minutes of joining one group, a seller posted WhatsApp details, where most transactions take place. The seller sent an guidebook and promised delivery within two days. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about weight, health issues or previous experience.
Product Details and Costs
Inside these communities, posts show black plastic packages with postal service labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at home with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20 milligrams. When questioned how long a injector should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for Telegram said it regularly monitored dangerous material on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are injecting materials they can’t verify. Even if the research behind retatrutide is sound, these online products may not include what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor connected the surge in demand to recent cost increases for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are using social media. But fake injections are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.
Her staff has previously seen patients injured by personal administration from unverified sources. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”
Producer Position
A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may subject patients to possibly serious medical dangers”.
